Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The main aim of this study was to evaluate the efficacy and safety of adding ribociclib to fulvestrant in men and postmenopausal women with hormone receptor positive (HR+), HER2-negative advanced breast cancer.
Epistemonikos ID: f6a64e9e2b5bc2539275e1bc322b69ab19e202f7
First added on: Oct 05, 2017